| Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease A Massot, D Pelegri, A Penalba, J Arenillas, C Boada, D Giralt, M Ribó, ... Atherosclerosis 218 (1), 181-187, 2011 | 50 | 2011 |
| Neurological complications of COVID‐19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic S Portela‐Sánchez, A Sánchez‐Soblechero, PJ Melgarejo Otalora, ... European Journal of Neurology 28 (10), 3339-3347, 2021 | 46 | 2021 |
| Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results A Massot, R Vivanco, A Principe, J Roquer, R Rocamora Neurología (English Edition) 29 (2), 94-101, 2014 | 41 | 2014 |
| C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses JF Arenillas, A Massot, J Alvarez-Sabín, I Fernandez-Cadenas, ... Cerebrovascular Diseases 28 (1), 95-102, 2009 | 38 | 2009 |
| Comparing the Wada test and functional MRI for the presurgical evaluation of memory in temporal lobe epilepsy A Massot-Tarrús, K White, SM Mirsattari Current neurology and neuroscience reports 19, 1-14, 2019 | 34 | 2019 |
| Marijuana use in adults admitted to a Canadian epilepsy monitoring unit A Massot-Tarrús, RS McLachlan Epilepsy & Behavior 63, 73-78, 2016 | 31 | 2016 |
| Comparing the intracarotid amobarbital test and functional MRI for the presurgical evaluation of language in epilepsy A Massot-Tarrús, SR Mousavi, SM Mirsattari Current neurology and neuroscience reports 17, 1-15, 2017 | 27 | 2017 |
| Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine A Massot, A Gimenez-Arnau Journal of Pharmacology and Pharmacotherapeutics 5 (4), 271-274, 2014 | 23 | 2014 |
| Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts A Massot, M Navarro-Sobrino, A Penalba, JF Arenillas, D Giralt, M Ribo, ... Cerebrovascular diseases 35 (1), 81-88, 2013 | 23 | 2013 |
| Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: outcomes from an expanded access program V Villanueva, D Santos‐Carrasco, P Cabezudo‐García, A Gómez‐Ibáñez, ... Epilepsia open 8 (3), 918-929, 2023 | 20 | 2023 |
| Concordance between fMRI and Wada test for memory lateralization in temporal lobe epilepsy: a meta-analysis and systematic review A Massot-Tarrús, KP White, SR Mousavi, S Hayman-Abello, ... Epilepsy & Behavior 107, 107065, 2020 | 18 | 2020 |
| Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence A Massot, D Giralt, A Penalba, T Garcia-Berrocoso, M Navarro-Sobrino, ... Atherosclerosis 233 (1), 186-189, 2014 | 15 | 2014 |
| Coprolalia as a manifestation of epileptic seizures A Massot-Tarrús, SR Mousavi, C Dove, B Hayman-Abello, PA Derry, ... Epilepsy & Behavior 60, 99-106, 2016 | 14 | 2016 |
| EARLY‐ESLI study: Long‐term experience with eslicarbazepine acetate after first monotherapy failure V Villanueva, P Bermejo, J Montoya, M Toledo, A Gómez‐Ibáñez, ... Acta Neurologica Scandinavica 136 (3), 254-264, 2017 | 13 | 2017 |
| Outcome of temporal lobe epilepsy surgery evaluated with bitemporal intracranial electrode recordings A Massot-Tarrús, DA Steven, RS McLachlan, SM Mirsattari, D Diosy, ... Epilepsy Research 127, 324-330, 2016 | 13 | 2016 |
| Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study A Massot-Tarrús, YJ Yu, M AlKhateeb, SM Mirsattari Epilepsy & behavior 134, 108780, 2022 | 12 | 2022 |
| Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit A Massot-Tarrús, YJ Yu, M AlKhateeb, SM Mirsattari Epilepsy & Behavior 120, 108004, 2021 | 10 | 2021 |
| Evidence for cholinergic dysfunction in autosomal dominant Kufs disease P Jarrett, A Easton, K Rockwood, S Dyack, A McCollum, V Siu, ... Canadian Journal of Neurological Sciences 45 (2), 150-157, 2018 | 10 | 2018 |
| Safety study of long-term video-electroencephalogram monitoring M Ley, R Vivanco, A Massot, J Jimenez, J Roquer, R Rocamora Neurología (English Edition) 29 (1), 21-26, 2014 | 10 | 2014 |
| MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy V Villanueva, P Bermejo, J Montoya, A Massot-Tarrús, ML Galiano, ... Epilepsy & Behavior 97, 51-59, 2019 | 9 | 2019 |
Reza MousaviNuralogix CorporationVerified email at nuralogix.ai
